Prostatis Group LLC Vaneck ETF Tr J.P. Morgan Em L Transaction History

Prostatis Group LLC

$215 Billion
Q2 2023

A detailed history of Prostatis Group LLC transactions in Vaneck ETF Tr J.P. Morgan Em L stock. As of the latest transaction made, Prostatis Group LLC holds 29,522 shares of EMLC stock, worth $692,881. This represents 0.01% of its overall portfolio holdings.

Number of Shares

29,522

Holding current value

$692,881

% of portfolio

0.01%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 14, 2023	BUY	$24.83 - $25.71 $733,031 - $759,010	29,522 New	29,522 $29.5 Million

Others Institutions Holding EMLC

# of Institutions

257

Shares Held

87.6M

Call Options Held

Put Options Held

33.5K

Personal Capital Advisors Corp

8.83M
Shares

$207 Million
1.04% of portfolio
Sei Investments CO Oaks, PA

7.69M
Shares

$181 Million
0.26% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

7.24M
Shares

$170 Million
0.04% of portfolio
Asset Management One Co., Ltd.

5.56M
Shares

$130 Million
0.51% of portfolio
Varma Mutual Pension Insurance CO Varma, H9

4.1M
Shares

$96.2 Million
0.96% of portfolio

View Full List

About VANECK ETF TR J.P. MORGAN EM L

Ticker EMLC
Sector ETFs
Industry ETFs

More about EMLC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.

Account

Prostatis Group LLC Vaneck ETF Tr J.P. Morgan Em L Transaction History